ate Phase II study of Paricalcitol injectio
Phase 2
- Conditions
- Secondary Hyperparathyroidism
- Registration Number
- JPRN-jRCT2080220559
- Lead Sponsor
- Abbott Japan Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Aged 20 or over
Chronic kidney disease subjects receiving hemodialysis with secondary hyperparathyroidism
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method